OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Non–Small Cell Lung Cancer Metastatic Without Oncogenic Alterations
Nikolaj Frost, Martin Reck
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 6
Nikolaj Frost, Martin Reck
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 6
Showing 6 citing articles:
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
Yibei Wang, Mohammed Safi, Fred R. Hirsch, et al.
Nature Reviews Clinical Oncology (2025) Vol. 22, Iss. 3, pp. 200-214
Closed Access | Times Cited: 1
Yibei Wang, Mohammed Safi, Fred R. Hirsch, et al.
Nature Reviews Clinical Oncology (2025) Vol. 22, Iss. 3, pp. 200-214
Closed Access | Times Cited: 1
Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer
Jing Cheng, Wenwen Kang, Yueying Chen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Jing Cheng, Wenwen Kang, Yueying Chen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Recent advances in therapeutic strategies for non-small cell lung cancer
Po‐Lan Su, Naoki Furuya, Atif Asrar, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Po‐Lan Su, Naoki Furuya, Atif Asrar, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Benefit With No Target: Long-Term Outcomes of Chemoimmunotherapy in “PD-L1 Negative” NSCLC
Fabiana Perrone, Alessandro Leonetti, Marcello Tiseo, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 8, pp. 1128-1132
Closed Access
Fabiana Perrone, Alessandro Leonetti, Marcello Tiseo, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 8, pp. 1128-1132
Closed Access
Effectiveness and Safety of Atezolizumab in Patients with Locally-advanced or Metastatic Non-small Cell Lung Cancer after prior Chemotherapy under Real-life Conditions in Germany: The Non-interventional Study HYPERION
Niels Reinmuth, Christian Geßner, Thomas Schichtl, et al.
Cancer Treatment and Research Communications (2024) Vol. 43, pp. 100878-100878
Open Access
Niels Reinmuth, Christian Geßner, Thomas Schichtl, et al.
Cancer Treatment and Research Communications (2024) Vol. 43, pp. 100878-100878
Open Access
Expanding horizons in a new era for pathology: perspectives from the ASCO meeting
Federica Pezzuto, Rui Caetano Oliveira, Aleš Ryška
Virchows Archiv (2024)
Closed Access
Federica Pezzuto, Rui Caetano Oliveira, Aleš Ryška
Virchows Archiv (2024)
Closed Access
